Cotización Bmo Asset Allocation Fun... - FCUWX | ADVFN

US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
ETFs
Estados Unidos
NASDAQ
Bmo Asset Allocation Fund Series I Nl (FCUWX) Cotización

Bmo Asset Allocation Fund Series I Nl (FCUWX)

0.00

0.00

(0.00%)

Cerrado 22 Diciembre 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

Fuera de horario: -

Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Último Precio

-

Postura de Compra

-

Postura de Venta

-

Volume Operado de la Acción

-

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

-

Precio de Apertura

-

Hora

Última hora de negociación

Volumen promedio (3 m)

-

Volumen financiero

-

Precio Promedio Ponderado

-

No news to show yet.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	FU
4	0	0	0	0	0	0	0	FU
12	0	0	0	0	0	0	0	FU
26	0	0	0	0	0	0	0	FU
52	0	0	0	0	0	0	0	FU
156	0	0	0	0	0	0	0	FU
260	0	0	0	0	0	0	0	FU

FCUWX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Bmo Asset Allocation Fun...?

El precio actual de las acciones de Bmo Asset Allocation Fun... es US$ 0.00

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Bmo Asset Allocation Fun...?

Bmo Asset Allocation Fun... ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.5M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.63M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.84M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	8.58M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	5.96M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M

jcromeenes

jcromeenes 3 minutos hace

It's been a month since we saw $3.50. It already is a distant memory.

Hello Newman

Hello Newman 4 minutos hace

YES!!!! NO POLITICS at dinner!

looking 4 a win

looking 4 a win 4 minutos hace

Interesting in deed, I'll be adding I think.

ipiros

ipiros 4 minutos hace

Will Antonio come through for his shareholders in 2024? News drop tomorrow will be sweet.

dstock07734

dstock07734 5 minutos hace

Merck would pay $588m as upfront payment for a type of t-cell engager with clinical trial just being started a couple of months ago. Hypothetically if Merck wants to be the only collaborator for the first combination trial, how thick is the checkbook Merck has to put on the table?

M

skitahoe

skitahoe 7 minutos hace

Next week will be the 51st week in this year. Will we get news, none of us know, likewise in the 52nd week. If the company had new data, or approved products to report on, perhaps we'd see news during 5 to 15 of those weeks. With little such news, quarterlies and annual reports are to be anticipa

elks

elks 7 minutos hace

Cover time just saying

JJ8

JJ8 7 minutos hace

Sold my shares with profits and moved to several small AI stocks that Nvidia is buying and partnering with. GLTA

Jack Torrance

Jack Torrance 10 minutos hace

Yep. We have a 3-4 year cash runway with no debt, and already about $100M a year in revenue and rising rapidly, and a clear path to profitability, with contracts and collaborations with government entities and major corporations and universities. But somehow that all makes IonQ risky and worse than

Bubae

Bubae 11 minutos hace

This lawsuit is being handled in the Nevada district court so what about a federal angle? If GS Capital violated rule 144 when they converted the shares that would fall under the purview for the SEC, not the courts. I'm not going to waste time getting into the weeds of this lawsuit because it has be

janice shell

janice shell 11 minutos hace

Yes. Makes no sense at all. Sure, we massacred the Native Americans. It was a horror. it was bad and immoral. But it was also hundreds of years ago. That does not make it right.

But it DOES make the slaughter in Gaza something that's happening RIGHT NOW.

fuagf

fuagf 12 minutos hace

As hard as it is, hang in. Things have to get better. I'm off now. Sleep well, i hope.

Lime Time

Lime Time 13 minutos hace

Correct. TikTok is very scary for the transfer of information.

MJAM2020

MJAM2020 14 minutos hace

LoL @Fud azz rip...

imho
mj

fuagf

fuagf 15 minutos hace

That's right, he projects heaps. He was much more rational before he felt we had Israel all wrong, then he really went off track harking back to massacres of American Indians and Australian aborigines. As if that's got anything at all to do with today's Gaza war.

jtaylor042

jtaylor042 15 minutos hace

https://www.youtube.com/watch?v=rBeNQBoPyfk YouTube of Bosch IET / Manufacturing

Dr. Bosch's slide "The Past" is at 3:23. He describes the early relationship.

Alley-oop

Alley-oop 16 minutos hace

style="white-space: pre-wrap; caret-color: rgb(255, 255, 255); color: rgba(255, 255, 255, 1); font-size: 15px; background-color: rgba(0, 0, 0, 1)"https://x.com/JustInTimeMsngr/status/1870206864530776075

janice shell

janice shell 16 minutos hace

The younger generation gets news from podcasts, social media, news apps on phones where people can comment, and through networking.

Which is to say those people get no real news at all. And that accounts for the utter stupidity of the Trump threads at what's become of Twitter.

bar1080

bar1080 17 minutos hace

IJH 2024 YTD performance up 12.5 %

Bmo Asset Allocation Fun...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones